“… 10 , 33 In observational studies, multiple white and flat elevated lesions were found to be significantly associated with PPI use (OR, 3.58; 95% CI, 1.94 to 6.61), H. pylori eradication therapy (OR, 2.11; 95% CI, 1.08 to 4.11), female sex (OR, 1.92; 95% CI, 1.19 to 3.12), aging (OR, 1.05; 95% CI, 1.02 to 1.08), and moderate to severe atrophic gastritis (OR, 2.63; 95% CI, 1.52 to 5.63). 12 , 33 - 35 These lesions are also related with administration of histamine receptor antagonists and H. pylori eradication, and are therefore not uniquely associated with chronic PPI use. Furthermore, these lesions can be misdiagnosed as intestinal metaplasia.…”